Failing kidneys stop producing erythropoietin and stop activating vitamin D, which is why anaemia and bone disease are near-universal in dialysis.
What to know
- Anaemia is treated with iron and erythropoiesis-stimulating agents, guided by regular monitoring.
- Mineral and bone disorder is managed with phosphate binders, vitamin D analogues and dietary phosphate control.
- Uncontrolled phosphate and PTH cause vascular calcification — the damage is cardiovascular, not only skeletal.
- Bone pain, fractures or persistent itching should be reported rather than tolerated.
Talk to your care team
This topic is part of Monitoring & Long-term Care, one of ten modules in the Trivita Learning Hub. If anything here contradicts what your own nephrologist or dialysis nurse has told you, follow your care team — they know your prescription, your access and your history.
Trivita's dialysis nurses answer our care line 24 hours a day on 055 242 1070, including for people who are not yet our patients.
Education, not medical advice. This page explains home hemodialysis in general terms for patients and care partners in the UAE. It is reviewed by Trivita's Medical Director but cannot account for your individual circumstances. Never change a prescription, medication or technique based on this page alone.